STOCK TITAN

Sanara MedTech (SMTI) EPS by Year

SMTI NASDAQ

Sanara MedTech Inc. lost $4.36 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $3.72 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sanara MedTech Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$4.36
YoY n/m
5Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SMTI EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)-$3.72-$4.36n/m-$1.14n/m-$0.52n/m-$1.00n/m-$1.08n/m-$0.76-$1.32$0.00n/m$0.00-$0.01-$0.02n/m-$0.03n/m-$0.05n/m-$0.03n/m-$0.23

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

SMTI EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.05n/m$0.05n/m-$0.32-$3.40n/m-$0.23n/m-$0.41n/m-$0.18n/m-$0.34n/m-$0.41n/m-$0.21n/m-$0.03n/m-$0.13n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Sanara MedTech Inc. financials

Frequently Asked Questions

What was Sanara MedTech Inc.'s diluted earnings per share in fiscal year 2025?

Sanara MedTech Inc. lost $4.36 per diluted share in fiscal year 2025.

How fast is Sanara MedTech Inc.'s diluted earnings per share growing?

Sanara MedTech Inc. (SMTI) reported a loss of $1.14 per diluted share in fiscal year 2024 and a loss of $4.36 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What is Sanara MedTech Inc.'s diluted earnings per share over the last twelve months?

Sanara MedTech Inc. (SMTI) reported a loss of $3.72 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Sanara MedTech Inc. (SMTI) diluted earnings per share went from -$0.23 in fiscal year 2011 to -$4.36 in fiscal year 2025.

Sanara MedTech Inc. (SMTI) reported -$0.05 in diluted earnings per share in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Sanara MedTech Inc. (SMTI) reported on that line in every period on record.